酸素供給器市場：製品別、用途別-2025～2030年の世界予測

酸素供給器市場は、2023年に22億8,000万米ドルと評価され、2024年には25億1,000万米ドルに達すると予測され、CAGR 10.54％で成長し、2030年には46億1,000万米ドルになると予測されています。

酸素供給器市場の範囲は、酸素供給システムを含む医療と産業用途における重要な役割を中心に展開されています。酸素供給装置は主に手術、特に心肺バイパス（CPB）や体外膜酸素供給（ECMO）で使用され、重要な酸素供給をサポートする重要な装置です。その必要性は、外科的介入を必要とする心疾患や呼吸器疾患の有病率が増加していることに加え、高齢者の増加によって強調されています。適用範囲は病院から外来手術センターまで、成人患者と小児患者の両方に対応し、最終用途には臨床現場や新しい治療技術を研究する研究所が含まれます。市場洞察によると、心血管疾患の増加や膜型酸素供給装置などの酸素供給器技術の進歩が成長の主要促進要因となっています。さらに、低侵襲手術へのシフトが効率的な酸素供給システムの需要を強化しています。しかし、高コスト、償還の課題、複雑な規制状況などの制約が市場拡大の障害となっています。ビジネス機会は、発展途上国における医療インフラの拡大と、ポータブルでコンパクトな酸素供給装置への需要の高まりにあり、設計と機能性における技術的進歩への道を開くものです。企業への調査提言としては、研究開発に投資して製品効率を高め、戦略的パートナーシップを結んで市場範囲を広げることが挙げられます。小型化とバイオテクノロジーの統合における革新は、性能と使いやすさを最適化し、個別化医療の動向と一致させる道を提供する可能性があります。市場は緩やかな成長の特徴を示すが、規制ポリシーの変動や、先進的人工呼吸支援メカニズムのような代替技術からの競争圧力により、潜在的な変動性を持っています。費用対効果が高く患者に優しいソリューションに焦点を当て続けることで、企業は競争優位に立つことができます。したがって、増大する臨床需要に対応する技術革新を促進することが、酸素供給器セグメントで市場シェアを獲得し、成長を持続させるために極めて重要となります。

市場力学：急速に進化する酸素供給器市場の主要市場洞察を公開

酸素供給器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 外科手術件数の増加
  • 心臓と呼吸器疾患の有病率の増加
  • 世界の高齢者の増加
• 市場抑制要因
  • 高コストと複雑な手術
• 市場機会
  • 膜技術の進化
  • 斬新で先進的な酸素供給装置の採用
• 市場課題
  • 血液と空気の直接接触に対する懸念

ポーターのファイブフォース：酸素供給器市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：酸素供給器市場における外部からの影響の把握

外部マクロ環境要因は、酸素供給器市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：酸素供給器市場における競合情勢の把握

酸素供給器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：酸素供給器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、酸素供給器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：酸素供給器市場における成功への道筋を描く

酸素供給器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 外科手術件数の増加
    • 心臓や呼吸器疾患の増加
    • 世界中で高齢化が進む
  • 抑制要因
    • 高コストで操作が複雑
  • 機会
    • 膜技術の進化酸素供給器
    • 新型と先進的な酸素供給装置の採用
  • 課題
    • 血液と空気の直接接触の懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 酸素供給器市場：製品別

• イントロダクション
• バブル酸素供給器
• 膜酸素供給器

第7章 酸素供給器市場：用途別

• イントロダクション
• 心臓
• 体外心肺蘇生
• 呼吸器

第8章 南北アメリカの酸素供給器市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の酸素供給器市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの酸素供給器市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Braile Biomedica
• Chalice Medical Ltd.
• Getinge AB
• Livanova plc
• MC3 Cardiopulmonary
• Medtronic plc
• Microport Scientific Corporation
• Nipro Corporation
• Owgels Group
• Precision Medical, Inc.
• Rectus Medical
• Terumo Medical Corporation
• Xenios AG

LIST OF FIGURES

• FIGURE 1. OXYGENATOR MARKET RESEARCH PROCESS
• FIGURE 2. OXYGENATOR MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL OXYGENATOR MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL OXYGENATOR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL OXYGENATOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL OXYGENATOR MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL OXYGENATOR MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OXYGENATOR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL OXYGENATOR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS OXYGENATOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS OXYGENATOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES OXYGENATOR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES OXYGENATOR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC OXYGENATOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC OXYGENATOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OXYGENATOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OXYGENATOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. OXYGENATOR MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. OXYGENATOR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. OXYGENATOR MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL OXYGENATOR MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OXYGENATOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OXYGENATOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OXYGENATOR MARKET DYNAMICS
• TABLE 7. GLOBAL OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OXYGENATOR MARKET SIZE, BY BUBBLE OXYGENATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OXYGENATOR MARKET SIZE, BY MEMBRANE OXYGENATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OXYGENATOR MARKET SIZE, BY CARDIAC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OXYGENATOR MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL OXYGENATOR MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS OXYGENATOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. CANADA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. CANADA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES OXYGENATOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC OXYGENATOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CHINA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CHINA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. INDIA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. INDIA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA OXYGENATOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ITALY OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ITALY OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. POLAND OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. POLAND OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. QATAR OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. QATAR OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM OXYGENATOR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM OXYGENATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. OXYGENATOR MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. OXYGENATOR MARKET, FPNV POSITIONING MATRIX, 2023

The Oxygenator Market was valued at USD 2.28 billion in 2023, expected to reach USD 2.51 billion in 2024, and is projected to grow at a CAGR of 10.54%, to USD 4.61 billion by 2030.

The scope of the oxygenator market revolves around its critical role in medical and industrial applications involving oxygen delivery systems. Oxygenators are essential devices used primarily in surgeries, particularly cardiopulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO), providing vital oxygenation support. Their necessity is underscored by the increasing prevalence of cardiac and respiratory disorders necessitating surgical interventions, alongside the growing geriatric population. The application scope extends from hospitals to ambulatory surgical centers, catering to both adult and pediatric patients, while their end-use includes clinical settings and research laboratories exploring novel therapeutic techniques. Market insights reveal that the rising incidences of cardiovascular diseases and advancements in oxygenator technology, such as membrane oxygenators, are key drivers of growth. Further, the shift towards minimally invasive surgeries bolsters the demand for efficient oxygenation systems. However, limitations such as high costs, reimbursement challenges, and the complex regulatory landscape pose hindrances to market expansion. Opportunities lie in the expanding health infrastructure in developing nations and the growing demand for portable and compact oxygenators, paving the way for technological advancements in design and functionality. Recommendations for businesses include investing in research and development to enhance product efficiencies and forging strategic partnerships to widen market reach. Innovations in miniaturization and biotechnology integration may offer pathways to optimize performance and user-friendliness, aligning with personalized medicine trends. The market exhibits characteristics of gradual growth with potential volatility due to fluctuating regulatory policies and competitive pressures from substitute technologies like advanced ventilatory support mechanisms. Continued focus on cost-effective and patient-friendly solutions can offer businesses a competitive edge. Thus, fostering innovation that meets the increasing clinical demands will be crucial for capturing market share and sustaining growth in the oxygenator sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oxygenator Market

The Oxygenator Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in number of surgical procedures
  • Growing prevalence of cardiac and respiratory problems
  • Rising geriatric population across the globe
• Market Restraints
  • High cost and complex operation
• Market Opportunities
  • Evolution of membrane oxygenator technology
  • Introduction of novel and advanced oxygenators
• Market Challenges
  • Concern about direct contact of blood and air

Porter's Five Forces: A Strategic Tool for Navigating the Oxygenator Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oxygenator Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oxygenator Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oxygenator Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oxygenator Market

A detailed market share analysis in the Oxygenator Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oxygenator Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oxygenator Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oxygenator Market

A strategic analysis of the Oxygenator Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oxygenator Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Braile Biomedica, Chalice Medical Ltd., Getinge AB, Livanova plc, MC3 Cardiopulmonary, Medtronic plc, Microport Scientific Corporation, Nipro Corporation, Owgels Group, Precision Medical, Inc., Rectus Medical, Terumo Medical Corporation, and Xenios AG.

Market Segmentation & Coverage

This research report categorizes the Oxygenator Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Bubble Oxygenator and Membrane Oxygenator.
• Based on Application, market is studied across Cardiac, Extracorporeal Cardiopulmonary Resuscitation, and Respiratory.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in number of surgical procedures
    • 5.1.1.2. Growing prevalence of cardiac and respiratory problems
    • 5.1.1.3. Rising geriatric population across the globe
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and complex operation
  • 5.1.3. Opportunities
    • 5.1.3.1. Evolution of membrane oxygenator technology
    • 5.1.3.2. Introduction of novel and advanced oxygenators
  • 5.1.4. Challenges
    • 5.1.4.1. Concern about direct contact of blood and air
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Oxygenator Market, by Product

• 6.1. Introduction
• 6.2. Bubble Oxygenator
• 6.3. Membrane Oxygenator

7. Oxygenator Market, by Application

• 7.1. Introduction
• 7.2. Cardiac
• 7.3. Extracorporeal Cardiopulmonary Resuscitation
• 7.4. Respiratory

8. Americas Oxygenator Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Oxygenator Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Oxygenator Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Braile Biomedica
• 3. Chalice Medical Ltd.
• 4. Getinge AB
• 5. Livanova plc
• 6. MC3 Cardiopulmonary
• 7. Medtronic plc
• 8. Microport Scientific Corporation
• 9. Nipro Corporation
• 10. Owgels Group
• 11. Precision Medical, Inc.
• 12. Rectus Medical
• 13. Terumo Medical Corporation
• 14. Xenios AG